BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23840707)

  • 1. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
    Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
    PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer.
    Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ
    Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
    Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
    Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EFEMP1 suppresses growth and invasion of lung cancer cells 
by downregulating matrix metalloproteinase-7 expression].
    Lang Y; Meng J; Song X; Chen X
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):92-7. PubMed ID: 25676403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
    Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
    J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
    Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
    Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
    Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
    Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
    Qiu C; Bu X; Jiang Z
    Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway.
    Ni M; Zhao Y; Wang X
    Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer.
    Bao W; Fan Q; Luo X; Cheng WW; Wang YD; Li ZN; Chen XL; Wu D
    Oncol Rep; 2013 Aug; 30(2):723-30. PubMed ID: 23708264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.
    Yang T; Zhang H; Qiu H; Li B; Wang J; Du G; Ren C; Wan X
    Oncotarget; 2016 May; 7(18):25712-25. PubMed ID: 27015552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.
    Yoshida K; Nagasaka T; Umeda Y; Tanaka T; Kimura K; Taniguchi F; Fuji T; Shigeyasu K; Mori Y; Yanai H; Yagi T; Goel A; Fujiwara T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1557-69. PubMed ID: 27095449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.
    Gu Z; Ding G; Liang K; Zhang H; Guo G; Zhang L; Cui J
    Med Sci Monit; 2014 Jun; 20():980-7. PubMed ID: 24929083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.